<DOC>
	<DOCNO>NCT00025727</DOCNO>
	<brief_summary>The purpose study test 2 different dose regimen GW433908/ritonavir ( RTV ) versus lopinavir ( LPV ) /RTV give 2 active reverse transcriptase inhibitor ( RTIs ) , patient take anti-HIV drug without success .</brief_summary>
	<brief_title>Comparison Two Dosing Regimens GW433908/Ritonavir Versus Lopinavir/Ritonavir 48 Weeks HIV Patients Who Have Taken Protease Inhibitors Experienced Virological Failure</brief_title>
	<detailed_description>Patients receive 2 dose regimen GW433908/RTV LPV/RTV , combination 2 active RTIs , fail first second protease inhibitor-containing regimen . Patients required therapy time screen must remain therapy Day 1 .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Fosamprenavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<mesh_term>HIV Protease Inhibitors</mesh_term>
	<mesh_term>Protease Inhibitors</mesh_term>
	<criteria>Inclusion Criteria Patients may eligible study : Have viral load 1,000 copies/ml . Have take protease inhibitor ( PIs ) . Have take PI drug least 12 straight week virologic failure PIs . Are take antiretroviral therapy . Are male female least 13 year old ( 18 local requirement ) provide consent parent guardian 18 . Are females unable child , able child , pregnant agree use approve birth control . Exclusion Criteria Patients eligible study : Have take APV LPV 1 week . Have take tenofovir disoproxil fumarate ( TDF ) adefovir . Have take 2 PIs . Are unable take 2 active RTIs , specify study . Have active CDC Category C disease . Have certain abnormal laboratory test . Are pregnant breastfeeding . Have serious health problem ( e.g. , diabetes , heart problem , hepatitis ) might risk safety patient . Have history significant kidney bone disease . Are able take drug mouth absorb . Have pancreatitis hepatitis within previous 6 month . Have drug allergy allergy might cause problem study . Have radiation chemotherapy within 28 day take study drug , expect need study . Have take drug affect immune system ( corticosteroid , interleukin , interferon ) drug antiHIV activity ( hydroxyurea foscarnet ) within 28 day prior take study drug . Have HIV vaccine within 3 month take study drug . Have take certain drug within 28 day prior take study drug , expect need study . Use alcohol illicit drug way doctor feel would interfere study . Are able take study drug . Have inadequate kidney function .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2002</verification_date>
	<keyword>HIV-1</keyword>
	<keyword>HIV Protease Inhibitors</keyword>
	<keyword>Ritonavir</keyword>
	<keyword>RNA , Viral</keyword>
	<keyword>Anti-HIV Agents</keyword>
	<keyword>Viral Load</keyword>
	<keyword>ABT 378</keyword>
	<keyword>VX-175</keyword>
</DOC>